Into esingayaziyo malunga neengozi ze-aspirin kunye nobungozi bokuyithatha

Izigidi zabantu, kubandakanywa nenani elikhulu "labantu abanempilo", bathatha ipilisi yemihla ngemihla ye-aspirin, bekholelwa ukuba iya kubagcina besempilweni.

Kwelinye icala, kukho iqela loogqirha abaphezulu baseBritani kunye nezazinzulu eziye zafumanisa ukuba ukuthatha iasprini ngokuchasene nemvelaphi yale nkolelo idumileyo ayiwunciphisi umngcipheko wokuhlaselwa sisifo sentliziyo. Bade bafumanisa ukuba oku kuphinda kabini amathuba okulaliswa esibhedlele ngenxa yokopha ngaphakathi.

Yaye iziphumo zolo hlolisiso, ezapapashwa liphephandaba laseBritani i<em>The Daily Telegraph, zabonisa ukuba iingozi zokusela ipilisi yeasprini kubantu abasempilweni zingaphezu kweengenelo zayo. Oogqirha bagxininisa ukuba izigulane esele zihlaselwa sisifo senhliziyo kufuneka ziyeke ukuthatha ichiza.

Endaweni yoko, uphononongo lucebise ukuba kufakwe i-aspirin "kwipilisi esetyenziswa ngeendlela ezininzi" ene-anti-cholesterol kunye neyeza loxinzelelo lwegazi abanokuthi abo bangaphezulu kwamashumi amahlanu banokuyithatha yonke imihla.

Iingcali zathi inani elikhulu labantu abaxhalabileyo bathatha i-aspirin njengendawo yokukhusela, ngenxa yokuba ubukho beli chiza lisesandleni ngeli xesha lexesha lenza likhuseleke ngokupheleleyo.

Iziphumo zolunye uphando olwenziwa eSkotlani lwaza lwaboniswa kwi-European Society of Cardiology Congress e-Barcelona luqinisekisa ubungqina obukhulayo bokuba iingozi zalo mkhuba zigqithise inzuzo kubantu abanempilo.

Kuphononongo oludlulileyo kulo nyaka, izazinzulu zaseOxford zafumanisa ukuba nangona amathuba okuhlaselwa yintliziyo kwizigulana ezingazange zihlaselwe luhlaselo olunye zinokuncitshiswa ngesihlanu, ithuba lokopha kwesisu landa ngesithathu.